最新文章：伊维菌素和甲苯咪唑治疗案例——一位38岁的德克萨斯州女性，患有4期结直肠黏液癌，已转移至腹膜——3个月后报告——所有肿瘤都在缩小！一名38岁的德克萨斯州女性，患有4期结直肠黏液癌，癌细胞已转移至腹膜（她于2021年接种了两剂辉瑞新冠疫苗）。2025年8月，她开始：伊维菌素 60毫克/天甲苯咪唑 1400 毫克/天我经常被问到关于黏液性肿瘤的问题。他们是否对重新利用的药物有反应？答案是肯定的！黏液性肿瘤难以治疗，肿瘤科医生在治疗这类肿瘤方面的成功率很低。但他们对化疗+伊维菌素+甲苯达唑的联合治疗有反应。在这种情况下，反响相对温和，但各方面都有所改善。这位38岁的男子接种了两剂辉瑞新冠mRNA疫苗，现在却患上了四期结直肠癌。真是太不幸了……几乎可以肯定的是，这是一种mRNA诱导的涡轮癌。NEW ARTICLE: IVERMECTIN and MEBENDAZOLE Testimonial - 38 year old Texas woman with Stage 4 Colorectal Mucinous Cancer metastatic to peritoneum - reports after 3 months - all tumors shrinking!38 year old Texas woman with Stage 4 Colorectal Mucinous Cancer metastatic to peritoneum (she had two Pfizer COVID-19 Vaccines in 2021)In August 2025 she started:Ivermectin 60mg/dayMebendazole 1400mg/dayI get asked about mucinous tumors all the time. Do they respond to repurposed drugs?The answer is yes!Mucinous tumors are difficult to deal with and Oncologists have a very poor track record with them.But they do respond to the combination of chemo + Ivermectin + Mebendazole.In this case, the response has been relatively mild but still, improvement across the board.38 year old had 2 Pfizer COVID-19 mRNA Vaccines and now has Stage 4 Colorectal Cancer. What a tragedy...Almost certainly an mRNA Induced Turbo Cancer